The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma
- 1 July 2010
- journal article
- research article
- Published by Wiley in Parasite Immunology
- Vol. 32 (11-12) , 769-772
Abstract
The Toll‐like receptor (TLR) signalling pathway is the first system that defends against Leishmania. After recognising Leishmania as nonself, TLRs trigger NF‐κB expression. NF‐κB proceeds to the nucleus and promotes the transcription of pro‐inflammatory cytokines. TLR9 is thus an important factor in the induction of an effective immune response against Leishmania. We examined the pattern of TLR9 expression in 12 patients with cutaneous leishmaniasis caused by Leishmania braziliensis detected by polymerase chain reaction. Normal skin was analysed as a negative control. TLR9 expression was examined in the dermis and epidermis by immunohistochemical analysis of paraffin‐embedded biopsy tissue. TLR9 expression was primarily observed in the granuloma. The protein was detected in a few cells in the dermis. A lower expression level was detected in the epidermis of patients with leishmaniasis when compared with normal skin. The presence of TLR9 in the skin of patients with cutaneous leishmaniasis is associated with granuloma and expressed by macrophages.Keywords
This publication has 11 references indexed in Scilit:
- Immunohistochemistry and polymerase chain reaction on paraffin‐embedded material improve the diagnosis of cutaneous leishmaniasis in the Amazon regionInternational Journal of Dermatology, 2009
- Toll-Like Receptors and LeishmaniasisInfection and Immunity, 2008
- Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids – first reportInternational Journal of Dermatology, 2007
- Expression of TLR9 and its mRNA in the lesions of lichen planusCurrent Medical Science, 2007
- Toll-Like Receptor 9-Independent Suppression of Skin Inflammation by OligonucleotidesJournal of Investigative Dermatology, 2007
- NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCsJournal of Experimental Medicine, 2007
- IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?Gene Therapy, 2004
- Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2Molecular and Biochemical Parasitology, 2003
- Toll-Like Receptor Signaling PathwaysScience, 2003
- Correlation of factor XIIIa + dermal dendrocytes with paracoccidioidomycosis skin lesionsMedical Mycology, 2002